GlassScriptPhysician profile
Alexander J Larson
NPI 1265695019
$2,320.38
in general payments reported to CMS, 2019-2025
34 companies · $534 in 2025
The $534 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $260 · 2021: $290 · 2022: $271 · 2023: $461 · 2024: $267 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,262.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $322.15 | 2019-2025 | Veozah |
| Caldera Medical, INC | $205.91 | 2023 | Desara |
| Abbvie INC. | $187.87 | 2019-2024 | |
| Hologic Sales and Service, LLC | $179.35 | 2020-2025 | Myosure Tissue Removal Device, Omni Hysteroscope |
| Organon LLC | $151.95 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $133.27 | 2020-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $132.42 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $105.65 | 2019-2020 | |
| Coloplast Corp | $102.54 | 2022 | |
| Coopersurgical, INC. | $82.02 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Evofem Biosciences, INC. | $73.69 | 2020-2021 | |
| Therapeuticsmd, INC. | $68.27 | 2019-2021 | |
| Intuitive Surgical, INC. | $64.34 | 2024 | |
| Biogen, INC. | $54.37 | 2024-2025 | Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $41.57 | 2025 | Exparel |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $40.32 | 2025 | Stratafix, Vistaseal |
| Octapharma USA, INC. | $31.49 | 2025 | Fibryga |
| Medtronic, INC. | $29.32 | 2022 | |
| Sanofi Pasteur INC. | $28.99 | 2025 | |
| Conmed Corporation | $28.94 | 2024 | Airseal |
| Avion Pharmaceuticals | $27.83 | 2021-2022 | |
| Baxter Healthcare | $27.12 | 2025 | Perclot |
| Sumitomo Pharma America, INC. | $23.98 | 2025 | Gemtesa |
| Myovant Sciences INC. | $22.37 | 2021 | |
| Meditrina | $21.18 | 2025 | |
| Mallinckrodt Hospital Products INC. | $18.94 | 2020 | |
| Eisai INC. | $18.60 | 2024 | |
| Channel Medsystems, INC. | $17.81 | 2024 | |
| Allergan, INC. | $14.49 | 2019 | |
| Shield Therapeutics INC | $14.12 | 2023 | Accrufer |
| Aspira Women'S Health INC | $13.38 | 2021 | |
| Roche Diagnostics Corporation | $12.61 | 2019 | |
| Minerva Surgical, INC | $12.29 | 2019 | |
| Daiichi Sankyo INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.